Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.

Laje G, Cannon DM, Allen AS, Klaver JM, Peck SA, Liu X, Manji HK, Drevets WC, McMahon FJ.

Int J Neuropsychopharmacol. 2010 Jul;13(6):715-24. doi: 10.1017/S1461145709991027. Epub 2010 Jan 5.

2.

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.

Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, Manji HK, Drevets WC.

Biol Psychiatry. 2007 Oct 15;62(8):870-7. Epub 2007 Aug 2.

PMID:
17678634
3.

Positron emission tomography quantification of serotonin transporter binding in medication-free bipolar disorder.

Miller JM, Everett BA, Oquendo MA, Ogden RT, Mann JJ, Parsey RV.

Synapse. 2016 Jan;70(1):24-32. doi: 10.1002/syn.21868. Epub 2015 Oct 19.

4.

Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.

Murthy NV, Selvaraj S, Cowen PJ, Bhagwagar Z, Riedel WJ, Peers P, Kennedy JL, Sahakian BJ, Laruelle MA, Rabiner EA, Grasby PM.

Neuroimage. 2010 Aug 1;52(1):50-4. doi: 10.1016/j.neuroimage.2010.04.032. Epub 2010 Apr 18.

PMID:
20406689
5.

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

Meyer JH, Houle S, Sagrati S, Carella A, Hussey DF, Ginovart N, Goulding V, Kennedy J, Wilson AA.

Arch Gen Psychiatry. 2004 Dec;61(12):1271-9.

PMID:
15583118
6.

Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.

Hammoud DA, Endres CJ, Hammond E, Uzuner O, Brown A, Nath A, Kaplin AI, Pomper MG.

Neuroimage. 2010 Feb 1;49(3):2588-95. doi: 10.1016/j.neuroimage.2009.10.037. Epub 2009 Oct 21.

7.

Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.

Schneck N, Miller JM, Delorenzo C, Kikuchi T, Sublette ME, Oquendo MA, Mann JJ, Parsey RV.

J Affect Disord. 2016 Jan 15;190:494-498. doi: 10.1016/j.jad.2015.10.047. Epub 2015 Nov 4.

8.

Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.

Kraus C, Baldinger P, Rami-Mark C, Gryglewski G, Kranz GS, Haeusler D, Hahn A, Wadsak W, Mitterhauser M, Rujescu D, Kasper S, Lanzenberger R.

PLoS One. 2014 Sep 4;9(9):e106810. doi: 10.1371/journal.pone.0106810. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e113173. Gryglewsky, Gregor [corrected to Gryglewski, Gregor].

9.

Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography.

Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, Klaver JM, Charney DS, Manji HK, Drevets WC.

Biol Psychiatry. 2006 Aug 1;60(3):207-17.

PMID:
16875929
10.

5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB.

Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, Grasby P, Cowen P.

Am J Psychiatry. 2007 Dec;164(12):1858-65.

PMID:
18056241
11.

Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.

Reimold M, Batra A, Knobel A, Smolka MN, Zimmer A, Mann K, Solbach C, Reischl G, Schwärzler F, Gründer G, Machulla HJ, Bares R, Heinz A.

Mol Psychiatry. 2008 Jun;13(6):606-13, 557. doi: 10.1038/sj.mp.4002149. Epub 2008 Feb 12.

PMID:
18268503
12.

Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).

Nogami T, Takano H, Arakawa R, Ichimiya T, Fujiwara H, Kimura Y, Kodaka F, Sasaki T, Takahata K, Suzuki M, Nagashima T, Mori T, Shimada H, Fukuda H, Sekine M, Tateno A, Takahashi H, Ito H, Okubo Y, Suhara T.

Int J Neuropsychopharmacol. 2013 Jun;16(5):937-43. doi: 10.1017/S1461145712001009. Epub 2012 Oct 16.

PMID:
23067569
13.

Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype.

Reimold M, Smolka MN, Schumann G, Zimmer A, Wrase J, Mann K, Hu XZ, Goldman D, Reischl G, Solbach C, Machulla HJ, Bares R, Heinz A.

J Neural Transm (Vienna). 2007;114(5):635-9. Epub 2007 Jan 18.

PMID:
17225932
14.

A positron emission tomography study of the serotonergic system in relation to anxiety in depression.

Iscan Z, Rakesh G, Rossano S, Yang J, Zhang M, Miller J, Sullivan GM, Sharma P, McClure M, Oquendo MA, Mann JJ, Parsey RV, DeLorenzo C.

Eur Neuropsychopharmacol. 2017 Oct;27(10):1011-1021. doi: 10.1016/j.euroneuro.2017.07.009. Epub 2017 Aug 12.

15.
16.

Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.

Voineskos AN, Wilson AA, Boovariwala A, Sagrati S, Houle S, Rusjan P, Sokolov S, Spencer EP, Ginovart N, Meyer JH.

Psychopharmacology (Berl). 2007 Sep;193(4):539-45. Epub 2007 May 12.

PMID:
17497139
17.

Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.

Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP.

Neuropharmacology. 2016 Jun;105:142-153. doi: 10.1016/j.neuropharm.2015.12.022. Epub 2016 Jan 4.

PMID:
26764241
18.

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Horstmann S, Lucae S, Menke A, Hennings JM, Ising M, Roeske D, Müller-Myhsok B, Holsboer F, Binder EB.

Neuropsychopharmacology. 2010 Feb;35(3):727-40. doi: 10.1038/npp.2009.180. Epub 2009 Nov 18.

19.

Relationship between neuroticism personality trait and serotonin transporter binding.

Takano A, Arakawa R, Hayashi M, Takahashi H, Ito H, Suhara T.

Biol Psychiatry. 2007 Sep 15;62(6):588-92. Epub 2007 Mar 6.

PMID:
17336939
20.

Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.

Lanzenberger R, Kranz GS, Haeusler D, Akimova E, Savli M, Hahn A, Mitterhauser M, Spindelegger C, Philippe C, Fink M, Wadsak W, Karanikas G, Kasper S.

Neuroimage. 2012 Nov 1;63(2):874-81. doi: 10.1016/j.neuroimage.2012.07.023. Epub 2012 Jul 22.

PMID:
22828162

Supplemental Content

Support Center